Rodrigo et al. observed that there was no correlation between TMEM16A and clinical parameters in HNSSC and patients with TMEM16A-positive oropharyngeal tumors exhibited a significantly improved disease-specific survival, compared to hypopharyngeal, and laryngeal tumors (18). The gene discussed is ANO1; the disease is neoplasm of oropharynx.